NAS
ADPT icon

Nykredit A/S’s Adaptive Biotechnologies ADPT Stock Holding History

Nykredit A/S’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.7K Buy
+1,429
New +$21.9K ﹤0.01% 1608

Other funds holding ADPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Nykredit A/S's ADPT Position: Q2 2026 in Review

Nykredit A/S opened a new position in Adaptive Biotechnologies (ADPT) in Q2 2026: 1,429 shares worth $30.7K. The stake represents ﹤0.01% of the portfolio and ranks #1608 among its holdings.

213 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Nykredit A/S held 1,429 shares of Adaptive Biotechnologies worth $30.7K as of Q2 2026.
  • Adaptive Biotechnologies was a new Nykredit A/S position in Q2 2026.
  • Adaptive Biotechnologies made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #1608 holding.
  • 213 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.